18:40 , Mar 12, 2019 |  BC Extra  |  Financial News

InventisBio raises $70M series C to advance early stage pipeline

InventisBio raised $70 million in a series C round led by Advantech Capital and CMBI, the Chinese biotech announced late Monday. Pudong Innotek and existing investors Lilly Asia Ventures and OrbiMed Asia also participated in...
04:00 , Jan 4, 2019 |  BC Week In Review  |  Financial News

Suzhou Connect raises $55M series B, plans Phase Ib of dermatitis candidate

Suzhou Connect Biopharmaceuticals Ltd. (Taicang, China) raised $55 million on Jan. 2 in a series B round led by new investor Advantech Capital and announced plans to start a Phase Ib trial this quarter of...
01:06 , Jan 3, 2019 |  BC Extra  |  Financial News

Suzhou Connect raises $55M series B, plans Phase Ib of dermatitis candidate

Suzhou Connect Biopharmaceuticals Ltd. (Taicang, China) raised $55 million in a series B round Wednesday led by new investor Advantech Capital and announced plans to start a Phase Ib trial this quarter of its second...
19:41 , Nov 21, 2018 |  BioCentury  |  Finance

Alphamab's cancer cash

Alphamab Oncology spun out from Suzhou Alphamab Co. Ltd. and raised more than $100 million in a series A round to advance multiple cancer biologics through clinical testing. Investors in the round, which closed on...
23:22 , Nov 16, 2018 |  BC Extra  |  Financial News

Alphamab Oncology raises more than $100M series A

Immuno-oncology company Alphamab Oncology (Cayman) raised over $100 million in a series A round to accelerate development of its biologics including lead product KN035. Advantech Capital, PAG, China Venture Capital Fund, OrbiMed Advisors, Heritage Provider...
18:58 , Jul 13, 2018 |  BC Week In Review  |  Financial News

Sinovac Terminates Take-Private Deal, Raises $86.7M

Vaccines company Sinovac Biotech Ltd. (NASDAQ:SVA) said July 3 it raised $86.7 million in a private placement and terminated a planned deal to take the company private. A special committee formed by the company's board...
18:09 , Jul 3, 2018 |  BC Extra  |  Financial News

Sinovac terminates take-private deal, raises $86.7M

Vaccines company Sinovac Biotech Ltd. (NASDAQ:SVA) said it raised $86.7 million in a private placement and terminated a planned deal to take the company private. A special committee formed by the company's board determined that...
19:25 , Jan 26, 2018 |  BC Week In Review  |  Financial News

Harbour BioMed raises undisclosed series A+

Harbour BioMed (Shanghai, China) raised an undisclosed series A+ round on Jan. 22 led by new investor CDH Investments. Existing investor Advantech Capital participated. This month, Harbour granted BeiGene Ltd. (NASDAQ:BGNE) and ImmunoChina Pharmaceuticals Co....
00:08 , Jan 23, 2018 |  BC Extra  |  Financial News

CDH leads Harbour BioMed round

Harbour BioMed (Shanghai, China) raised an undisclosed series A+ round led by new investor CDH Investments. Existing investor Advantech Capital participated. This month, Harbour granted BeiGene Ltd. (NASDAQ:BGNE) and ImmunoChina Pharmaceuticals Co. Ltd. rights to...
19:08 , Jan 19, 2018 |  BioCentury  |  Finance

Incubating in China

C-Bridge Capital is one of the newer venture funds in Chinese healthcare seeking to bring mature platforms or programs from the Western market into China. Compared with most other Chinese VCs, however, C-Bridge is investing...